TrialAsia-Pacific journal of clinical oncology2020

Long-term persistence of immune response to the AS04-adjuvanted HPV-16/18 vaccine in Chinese girls aged 9-17 years: Results from an 8-9-year follow-up phase III open-label study.

Yuemei Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.